Begin main content

Eltrombopag

Last Updated: March 31, 2014
Result type: Reports
Project Number: SR0377
Product Line: Common Drug Review

Generic Name: Eltrombopag

Brand Name: Revolade

Manufacturer: GlaxoSmithKline

Indications: Thrombocytopenia associated with chronic hepatitis c infection

Submission Type: New Indication

Project Status: Complete

Date Recommendation Issued: March 18, 2015

Recommendation Type: List with criteria/condition